IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna

Public research footprint of IRCCS Azienda Ospedaliero - Universitaria di Bologna, compiled from the ClinicalTrials.gov public registry.

412

Registered studies

340

Active

252

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed or Refractory Multiple Myeloma (RRMM) · Atherosclerotic Cardiovascular Disease (ASCVD) · Breast Neoplasms · Neoplasm Metastasis

Recently updated registry entries

NCT05153239 — Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus… (Completed)
NCT07221500 — A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine… (Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at IRCCS Azienda Ospedaliero - Universitaria di Bologna?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.